Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Drug Discovery | Promotions & Moves
Reaction Biology Expands Executive Leadership Team
Appoints Alan Findlater as chief commercial officer and Emily Doyle as chief people officer.05.16.22
-
Breaking News | Collaborations & Alliances | Drug Discovery
Charles River and Valo Unveil Logica AI-Powered Drug Solution
Directly translates clients’ biological insights into optimized preclinical assets.04.27.22
-
Breaking News | Drug Discovery | Promotions & Moves
Carisma Names Michael Klichinsky as Chief Scientific Officer
Klichinsky co-founded the company in 2016.04.27.22
-
Breaking News | Drug Development | Drug Discovery
Biomunex Appoints Dr. Simon Plyte as Chief Scientific Officer
Plyte has a proven track record in drug discovery and development.04.25.22
-
Breaking News | Collaborations & Alliances | Drug Discovery
University of Tokyo and Astellas Enter Phase 2 of Collaboration
Partnership aims to co-create innovative new medicines and medical solutions.04.25.22
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Dragonfly Therapeutics Expands Research Collaboration with Abbvie
Will discover and develop Dragonfly's novel immunotherapies for new targets in autoimmune and fibrotic diseases.04.20.22
-
Collaborations & Alliances | Drug Development | Drug Discovery
Evotec Achieves Program Designation in BMS Collaboration
Leverages ASOs from Secarna Pharmaceuticals to tackle targets that are difficult to regulate or were previously deemed ‘undruggable.’04.12.22
-
Breaking News | Drug Discovery | Industry News
Discovery Life Sciences to Acquire Gentest Business from Corning
Biospecimen leader to create leading in vitro drug metabolism services offering.04.05.22
-
Breaking News | Drug Development | Drug Discovery
Zealand Pharma Restructures and Names New CEO
Will prioritize investment in its research and development pipeline programs and streamline its commercial operations.03.30.22
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Discovery | Process Development
The Role and Benefits of Polymeric Resins in Bioprocessing
Dorie Yontz of DuPont discusses its bioprocessing offering, the role of polymeric resins, and critical elements as they relate to manufacturing.Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.14.22
-
Drug Discovery
Indian Drug Makers Ramp Up Discovery Research
CDMOs augment capabilities.S. Harachand, Contributing Writer 03.08.22
-
Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News
Orbit Discovery and WuXi AppTec Enter Discovery Alliance
Sign agreement to access peptide discovery and optimization technologies.03.08.22
-
Collaborations & Alliances | Drug Discovery
Orbit Discovery, WuXi AppTec Ink Peptide Discovery, Optimization Pact
Will combine Orbit’s peptide discovery platform and experience with WuXi AppTec’s downstream capabilities.03.07.22
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Thermo Fischer Scientific and Symphogen Extend Collaboration
Supports biopharmaceutical discovery and development, aiding the creation of new cancer treatments.03.01.22
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Remix Therapeutics, Janssen Enter Small Molecule RNA Alliance
Collaboration leverages Remix’s REMaster platform for the discovery and development of small molecule therapies that modulate RNA processing.02.18.22
-
Breaking News | Drug Discovery | Industry News | Information Technology
Merck KGaA, Quris Partner on BioAI Platform for Clinical Safety Prediction
Merck KGaA to assess Quris’s BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches.02.10.22
-
Breaking News | Drug Discovery | Industry News
CAS Launches Expansion of the Discovery Technology into Life Sciences
Unlocks human-indexed insights from journals and patents in over 50 languages and 70 million biosequences curated by CAS scientists.02.01.22
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Discovery | Information Technology
Antiverse Alliance Aims to Iidentify Antibody Drug Candidates using AI
Demonstrates potential of Antiverse’s platform to reduce time and costs associated with antibody drug discovery.01.31.22
-
Breaking News | Collaborations & Alliances | Drug Discovery
Evotec, Boehringer Ingelheim Partner to Tackle Ophthalmologic Disorders
Aims to identify and validate promising targets and new approaches for therapeutic interventions.01.25.22
-
cGMP Manufacture | Clinical Trials | Drug Development | Drug Discovery | Information Technology
How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
AI and ML are set to have a measurable impact on drug development, clinical trials, supply chain, and commercial and regulatory processes.Arda Ural, Ernst & Young LLP 01.25.22
